VPCL logo

VPCDA - VPCL Share Price

A$0.004 0.0  0.0%

Last Trade - 14/11/18

Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £15.9k
Position in Universe th / 1913
Unlock VPCDA Revenue
Relative Strength (%)
1m +1.00%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Jun 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.031 1.40 1.82 0.013 0.14 0.051 +10.5%
Balance Sheet
FINANCIAL BRIEF: : For the six months ended 31 December 2020, HealthHouse International Ltd revenues decreased 97% to A$1K. Netloss decreased 20% to A$330K. Revenues reflect a decreasein demand for the Company's products and services due tounfavorable market conditions. Lower net loss reflectsFinance charges on Damstra early settlem decrease fromA$92K (expense) to A$0K, Directors fees decrease of 47% toA$78K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


VPCDA Revenue Unlock VPCDA Revenue

Net Income

VPCDA Net Income Unlock VPCDA Revenue

Normalised EPS

VPCDA Normalised EPS Unlock VPCDA Revenue

PE Ratio Range

VPCDA PE Ratio Range Unlock VPCDA Revenue

Dividend Yield Range

VPCDA Dividend Yield Range Unlock VPCDA Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
VPCDA EPS Forecasts Unlock VPCDA Revenue
Profile Summary

Health House International Limited, formerly VPCL Ltd, is an Australia-based International distributor of medicinal cannabis. The Company is principally engaged in acquiring locally-produced medicinal cannabis products and also imports medicinal cannabis from Canada, Germany, Netherlands, Macedonia, Slovenia, the United Kingdom (UK) and the United States of America (USA) and wholesales direct to Australian pharmacies, hospitals and researchers. It holds a number of strategic licenses to store, distribute, import, export and wholesale controlled drugs. The Company distributes various products, which includes iX Biopharma, ZELIRA Therapeutics, Ananda Hemp, Little Green Pharma, ANTG, HAPA and Satipharm.

Last Annual June 30th, 2020
Last Interim December 31st, 2020
Incorporated February 8, 2011
Public Since July 28, 2011
No. of Shareholders: 1,369
No. of Employees: n/a
Sector Healthcare
Industry Pharmaceuticals
Exchange Australian Stock Exchange - SEATS
Shares in Issue 1,130,846,123
Free Float (0.0%)
Eligible for
VPCDA Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for VPCDA
Upcoming Events for VPCDA
Frequently Asked Questions for VPCL
What is the VPCL share price?

As of 14/11/18, shares in VPCL are trading at A$0.004, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the VPCL share price performed this year?

Shares in VPCL are currently trading at A$0.004 and the price has moved by -63.64% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the VPCL price has moved by -72.15% over the past year.

What are the analyst and broker recommendations for VPCL?

Of the analysts with advisory recommendations for VPCL, there are there are currently "buy" , "hold" and "sell" recommendations. The overall consensus recommendation for VPCL is Not available. You can view the full broker recommendation list by unlocking its StockReport.

When will VPCL next release its financial results?

VPCL is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the VPCL dividend yield?

VPCL does not currently pay a dividend.

Does VPCL pay a dividend?

VPCL does not currently pay a dividend.

When does VPCL next pay dividends?

VPCL does not currently pay a dividend.

How do I buy VPCL shares?

To buy shares in VPCL you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of VPCL?

Shares in VPCL are currently trading at A$0.004, giving the company a market capitalisation of £n/a.

Where are VPCL shares listed? Where are VPCL shares listed?

Here are the trading details for VPCL:

Country of listing: Australia
Exchange: ASX
Ticker Symbol: VPCDA
What kind of share is VPCL?

We were not able to load our ranking data for VPCL

Is there a VPCL share price forecast 2021?

We were not able to load any forecast data for VPCL.

How can I tell whether the VPCL share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like VPCL. Over the past six months, the relative strength of its shares against the market has been -7.29%. At the current price of A$0.004, shares in VPCL are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the VPCL PE Ratio?

We were not able to find PE ratio data for VPCL.

Who are the key directors of VPCL?

VPCL's management team is headed by:

Russell Francis - CEO
Justin Pante - CTO
Daniel Rohr - CFO
Mews Lee - DRC
Chris Mews - NED
David Wheeler - CHM
Michael Rann - NED
Tim Slate - SEC
Who are the major shareholders of VPCL?

Here are the top five shareholders of VPCL based on the size of their shareholding:

Similar to VPCDA
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.